Main Session
Sep 27
PQA 01 - Gastrointestinal Cancer and Central Nervous System

2111 - Gliofocus: A Global, Open-Label, Randomized Phase 3 Study Comparing Niraparib with Temozolomide in Newly Diagnosed MGMT-Unmethylated Glioblastoma

03:00pm - 04:00pm ET
Poster Hall - Exhibit Hall A

Presenter(s)

William Kennedy, MD - Barrow Neurological Institute, Phoenix, AZ